A Case of Castration-Resistant Prostate Cancer with Fatal Convulsive Seizure after Administration of Enzalutamide

Enzalutamide, an androgen receptor antagonist, is a standard drug for the treatment of castrationresistant prostate cancer. A 77-year-old man developed a seizure after administration of enzalutamide. The patient presented with general fatigue and high fever approximately 5 weeks after oral administr...

Description complète

Détails bibliographiques

Publié dans:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 10 vom: 05. Okt., Seite 431-433
Auteur principal:	Iwanishi, Toshichika (Auteur)
Autres auteurs:	Yumiba, Satoru, Koida, Youhei, Kobayashi, Masao, Komori, Kazuhiko, Ono, Yutaka
Format:	Article en ligne
Langue:	Japanese
Publié:	2017
Accès à la collection:	Hinyokika kiyo. Acta urologica Japonica
Sujets:	Case Reports Journal Article Review Prostate cancer Seizure Benzamides Nitriles Phenylthiohydantoin 2010-15-3 enzalutamide 93T0T9GKNU